Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Income from Continuing Operations (2019 - 2025)

Volitionrx filings provide 9 years of Income from Continuing Operations readings, the most recent being 260595.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 49.54% to 260595.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 5262408.0, a 32.81% increase, with the full-year FY2025 number at 146302.0, down 49.58% from a year prior.
  • Income from Continuing Operations hit 260595.0 in Q4 2025 for Volitionrx, up from 31433.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 516444.0 in Q4 2024 to a low of 9521927.0 in Q2 2023.
  • Median Income from Continuing Operations over the past 5 years was 37528.5 (2021), compared with a mean of 2424190.65.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 791.1% in 2022 and later crashed 12585.14% in 2023.
  • Volitionrx's Income from Continuing Operations stood at 73088.0 in 2021, then grew by 28.74% to 94092.0 in 2022, then plummeted by 9380.53% to 8732237.0 in 2023, then soared by 105.91% to 516444.0 in 2024, then tumbled by 49.54% to 260595.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 260595.0 (Q4 2025), 31433.0 (Q3 2025), and 29992.0 (Q2 2025) per Business Quant data.